Compass Wealth Management LLC Has $4.50 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Compass Wealth Management LLC cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 14.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,007 shares of the company's stock after selling 2,139 shares during the period. Compass Wealth Management LLC's holdings in HCA Healthcare were worth $4,495,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in the business. Maj Invest Holding A S bought a new position in shares of HCA Healthcare during the 1st quarter worth about $109,823,000. Concurrent Investment Advisors LLC raised its holdings in HCA Healthcare by 5.2% in the 1st quarter. Concurrent Investment Advisors LLC now owns 2,142 shares of the company's stock valued at $740,000 after acquiring an additional 106 shares in the last quarter. Seascape Capital Management grew its holdings in shares of HCA Healthcare by 0.9% during the 1st quarter. Seascape Capital Management now owns 13,575 shares of the company's stock worth $4,691,000 after purchasing an additional 117 shares in the last quarter. Wayfinding Financial LLC bought a new position in HCA Healthcare in the first quarter worth $113,000. Finally, Olde Wealth Management LLC bought a new stake in HCA Healthcare in the 1st quarter valued at $76,000. Institutional investors own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Trading Down 1.4%

HCA stock traded down $5.20 during trading on Friday, hitting $372.84. The company had a trading volume of 943,125 shares, compared to its average volume of 1,463,446. The firm has a 50-day moving average price of $371.55 and a 200-day moving average price of $339.38. The stock has a market cap of $89.69 billion, a price-to-earnings ratio of 16.58, a PEG ratio of 1.30 and a beta of 1.47. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same period last year, the company earned $5.36 earnings per share. The company's revenue was up 5.7% on a year-over-year basis. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date of this dividend was Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.81%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Wells Fargo & Company upgraded HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Guggenheim started coverage on HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating for the company. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday. Finally, Barclays set a $416.00 price target on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Seven analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $395.71.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.